Navigation Links
DNA Sequencing Service from Yorkshire Bioscience Ltd

ProductsDNA Sequencing Service from Yorkshire Bioscience Ltd
Company Yorkshire Bioscience Ltd
Item DNA Sequencing Service
Price $15.00
Description DNA sequencing - plasmids or PCR fragments, 3-7 working days service.
Info Yorkshire Bioscience LtdYorkshire Bioscience Ltd
Customer Service: +44(0)1904561592
Fax Number: +44(0)1904567621
Web Site: http://www.york-bio.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. Thermo Sequenase Dye Primer Manual Cycle Sequencing Kit from USB Corp.
2. General DNA Sequencing Services from Polymorphic DNA Technologies, Inc.
3. Lambda GT11 Reverse DNA Sequencing Primer from EPICENTRE Biotechnologies
4. Lambda GT11 Forward DNA Sequencing Primer from EPICENTRE Biotechnologies
5. Full-Length "Primer Walk" Sequencing from Seqwright
6. Whole-Genome Shotgun Sequencing from Seqwright
7. FDA-Submission Quality DNA Sequencing from Seqwright
8. QuickLane Individual Sample Sequencing from Agencourt Bioscience
9. Whole Genome Sequencing from Agencourt Bioscience
10. Primer Walking Sequencing Service from Agencourt Bioscience
11. cDNA Sequencing & Finishing from Agencourt Bioscience
, Premium quality synthesis and purification , You provide the sequence, we'll do the rest , Rigorous quality control , Your choice of purification method, amount and format , Available annealed...
... provides the premium quality siRNAs you need ... can be readily ordered online by providing ... by providing the sense and antisense siRNA ... and Silencer Pre-designed siRNAs, which are already ...
... custom siRNA service provides the premium quality ... research. Custom siRNAs can be readily ordered ... target sequence, or by providing the sense ... Ambion's Silencer Validated and ...
Human SDNSF/MCFD2 Biotinylated Affinity Purified PAb...
Biology Products:
(Date:5/19/2015)... DUBLIN , May 19, 2015 /PRNewswire/ ... ) has announced the addition of the  ... their offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,A ... provides an in-depth analysis of the current ... introduction of gene-based tests, their working principles ...
(Date:5/14/2015)... YORK , May 14, 2015 /PRNewswire/ ... in identity verification and online remote proctoring, ... a software-as-a-service (SaaS) company and creator of ... customers of the two companies will benefit ... in Canvas. As a fully ...
(Date:5/11/2015)... May 11, 2015 Curemark LLC, a privately ... of a new Phase III double blind, randomized, placebo-controlled ... formulation, CM-AT, on all children ages 3-8 with Autism. ... Phase III double blinded clinical trial for CM-AT in ... of the digestive enzyme chymotrypsin. This new trial will ...
Breaking Biology News(10 mins):Global Genetic Testing Market Outlook 2018 2Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2
... macrophages, immune cells that can engulf and poison bacteria ... A new study from the University of Illinois disproves ... PLoS ONE , shows that macrophages focus their most ... targets outside the cytoplasm. Macrophages are voracious eaters ...
... research institutes, announced today the launch of three ... in extreme environments. The three selected genomes are ... and emperor penguin, and one altiplano animal: the ... carried out using Next-generation sequencing technologies, which have ...
... and drainage. Blood vessels feeding the tissues bring in ... While much is known about how blood vessels are ... Now though, Norrmn et al. have identified two of ... mouse embryo. The engineers are the transcription ...
Cached Biology News:New study overturns orthodoxy on how macrophages kill bacteria 2New study overturns orthodoxy on how macrophages kill bacteria 3Genome projects launched for three extreme-environment animals 2Genome projects launched for three extreme-environment animals 3
(Date:5/30/2015)... and RARITAN, N.J. , ... multi-center, open-label, two-part, single-arm Phase 2 MMY2002 (SIRIUS) ... investigational, human anti-CD38 monoclonal antibody – achieved an ... CI, 20.8-38.9), as assessed by an independent review ... The ORR was consistent among the pre-specified subgroups ...
(Date:5/29/2015)... , May 29, 2015 BerGenBio ... today announces that an abstract on the latest data ... of the Axl receptor tyrosine kinase, and BGB10C9, an ... has been published in conjunction with the 2015 American ... Chicago , May 29 - June 2, ...
(Date:5/29/2015)... Market Publishers Ltd and Shanghai ... partnership agreement for quality market research promotion on ... sell research reports worked out by Chem-Report. , ... upon the agreement: “Chem-Report is a Chinese company ... chemical markets on global and country levels. The ...
(Date:5/29/2015)... May 29, 2015  Caris Life Sciences ® ... the promise of precision medicine, today announced the ... the clinical utility of Caris Molecular Intelligence ® ... in helping to identify targeted treatment options for ... of the studies, results of which are to ...
Breaking Biology Technology:Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 2Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 3Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 4Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 5Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 6Data Show Daratumumab Achieved a Pronounced Overall Response Rate as a Single-Agent with Tolerable Safety Profile in Heavily Pre-Treated Multiple Myeloma Patients 7BGB324 and BGB10C9 Show Promise in Models of Pancreatic Cancer 2BGB324 and BGB10C9 Show Promise in Models of Pancreatic Cancer 3Market Publishers Ltd and Chem-Report Sign Partnership Agreement 2Market Publishers Ltd and Chem-Report Sign Partnership Agreement 3Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 2Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 3Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 4Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 5Multi-Platform Tumor Profiling from Caris Life Sciences Identifies Targeted Treatment Options for Patients with Rare and/or Aggressive Tumors 6